Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial

BACKGROUND: Subcutaneous immunotherapy (SCIT) has been proven as an effective therapy against some allergens for seasonal allergic rhinitis (SAR) patients unresponsive to intranasal corticosteroids and/or antihistamines but carries risk of systemic allergic reactions. Dupilumab blocks the shared rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Corren, Jonathan, Saini, Sarbjit S, Gagnon, Remi, Moss, Mark H, Sussman, Gordon, Jacobs, Joshua, Laws, Elizabeth, Chung, Elinore S, Constant, Tatiana, Sun, Yiping, Maloney, Jennifer, Hamilton, Jennifer D, Ruddy, Marcella, Wang, Claire Q, O’Brien, Meagan P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379710/
https://www.ncbi.nlm.nih.gov/pubmed/34429614
http://dx.doi.org/10.2147/JAA.S318892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379710/
https://www.ncbi.nlm.nih.gov/pubmed/34429614
http://dx.doi.org/10.2147/JAA.S318892

Ejemplares similares